Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors
Annals of Behavioral Medicine · 2023
DOI: 10.1093/abm/kaad048 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Behavioral Medicine, 2023. Verfasst von Jinghua An und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Ovarian Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, CDC HHS, CLC NIH HHS.
Abstract (Originalsprache)
Background
A theory-guided Tailored Counseling and Navigation (TCN) intervention successfully increased cancer genetic risk assessment (CGRA) uptake among cancer survivors at increased risk of hereditary breast and ovarian cancer (HBOC). Understanding the pathways by which interventions motivate behavior change is important for identifying the intervention’s active components.
Purpose
We examined whether the TCN intervention exerted effects on CGRA uptake through hypothesized theoretical mediators.
Methods
Cancer survivors at elevated risk for HBOC were recruited from three statewide cancer registries and were randomly assigned to three arms: TCN (n = 212), Targeted Print (TP, n = 216), and Usual Care (UC, n = 213). Theoretical mediators from the Extended Parallel Process Model, Health Action Planning Approach, and Ottawa Decision Support Framework were assessed at baseline and 1-month follow-up; CGRA uptake was assessed at 6 months. Generalized structural equation modeling was used for mediation analysis.
Results
The TCN effects were most strongly mediated by behavioral intention alone (β = 0.49 and 0.31) and by serial mediation through self-efficacy and intention (β = 0.041 and 0.10) when compared with UC and TP, respectively. In addition, compared with UC, the TCN also increased CGRA through increased perceived susceptibility, knowledge of HBOC, and response efficacy.
Conclusions
Risk communication and behavioral change interventions for hereditary cancer should stress a person’s increased genetic risk and the potential benefits of genetic counseling and testing, as well as bolster efficacy beliefs by helping remove barriers to CGRA. System-level and policy interventions are needed to further expand access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
- School of Public Health, The State University of New Jersey, New Brunswick, NJ, USA.
- Fred Hutchinson Cancer Center, Seattle, WA, USA.
- University of North Texas Health Science Center, Fort Worth, TX, USA.
ORCID-Profile: Jinghua An, Anita Y Kinney
Förderung
- NCI NIH HHS
- CDC HHS
- CLC NIH HHS
- NHLBI NIH HHS
- NIEHS NIH HHS
- ORFDO NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
An, J., Lu, S. E., McDougall, J., Walters, S. T., Lin, Y., Heidt, E., Stroup, A., Paddock, L., Grumet, S., Toppmeyer, D., & Kinney, A. Y. (2023). Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/kaad048
Vancouver
An J, Lu SE, McDougall J, Walters ST, Lin Y, Heidt E, et al. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors. Annals of Behavioral Medicine. 2023. doi:10.1093/abm/kaad048
BibTeX
@article{An2023,
author = {An, Jinghua and Lu, Shou-En and McDougall, Jean and Walters, Scott T and Lin, Yong and Heidt, Emily and Stroup, Antoinette and Paddock, Lisa and Grumet, Sherry and Toppmeyer, Deborah and Kinney, Anita Y},
title = {Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors},
journal = {Annals of Behavioral Medicine},
year = {2023},
doi = {10.1093/abm/kaad048}
}
EUVIMED